Johnson & Johnson s vaccine is less effective at preventing COVID-19 than other approved vaccines are, but experts say it could still be an important tool in curbing the pandemic.
Single-shot Johnson & Johnson vaccine 66 percent effective against moderate and severe illness washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson COVID-19 Vaccine Isn’t As Effective, But Has This Other Big Benefit
01/29/21 AT 8:59 AM
A third COVID-19 vaccine by Johnson & Johnson could be on the horizon, but while it could be beneficial to those who aren’t comfortable with the two doses needed by the Pfizer/BioNTech and Moderna vaccines, there is one major issue with the newest one to potentially hit the market its efficacy rate.
Following global clinical trials, the vaccine was proven to be 66% effective at preventing moderate and severe illness from COVID-19, according to The Washington Post. The trial found 85% efficacy at preventing severe disease overall and 72% effectiveness at preventing moderate to severe illness in the United States, but in areas where troubling new variants of the disease have emerged, the rate was much lower showing only 66% effectiveness in Latin America and 57% in South Africa.
UPDATED 9:46 AM ET Jan. 22, 2021 PUBLISHED 3:10 PM ET Jan. 21, 2021 PUBLISHED 3:10 PM EST Jan. 21, 2021
SHARE
MILWAUKEE â This week, after much discussion, Wisconsinites got some more clarity on which groups will be next up in the COVID-19 vaccine rollout.
Shots have previously been opened up to health care workers and long-term care facilities in Phase 1A, plus police and firefighters as the first chunk of 1B.
As soon as next Monday, older adults ages 65 and up will also be able to get their shots, the Department of Health Services announced this week. And experts on the State Disaster Medical Advisory Committee, which advises the DHS on vaccine distribution, voted Thursday to finalize the rest of their Phase 1B recommendations.
Updated: 5:25 PM CST Jan 20, 2021 A Wisconsin advisory committee added groups like teachers, grocery store workers and inmates to the list of those eligible to now receive the COVID-19 vaccine.Continuing Coverage: Coronavirus in WisconsinBut many residents with serious medical conditions have still been left out.The state s vaccine advisory group said some tough calls had to be made and even with that, nearly half of the state s population will be eligible for the vaccine in these first two phases.Phase 1B begins Monday.A 19-member statewide panel had the tough job of deciding who is in it. The state added this week residents age 65 and older. Beyond that, the category included a large segment that had been pressing for inclusion farmers and meat processors. They re close to the public, the public doesn t always follow social distancing or masking expectations, the workers have little or no control over their working environment, they re often in low paying jobs and the